Diabetes, Vol 44, Issue 12 1386-1391, Copyright © 1995 by American Diabetes Association

ARTICLES

Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans

SM Haffner, H Miettinen, SP Gaskill and MP Stern
Department of Medicine, University of Texas Health Science Center at San Antonio 78284, USA.

The relative importance of insulin resistance and abnormal insulin secretion as risk factors for the development of non-insulin-dependent diabetes mellitus (NIDDM) is still controversial. Few data are available on insulin secretion as a risk factor for the development of NIDDM, especially in subjects with normal glucose tolerance. We examined the relation of fasting insulin (as a marker of insulin resistance) and the ratio of change in insulin to change in glucose during the first 30 min after glucose ingestion (delta I30/delta G30) (as a marker of insulin secretion) as predictors of the 7-year development of NIDDM in 714 initially nondiabetic Mexican-Americans. NIDDM developed in 99 subjects. The relative risk of NIDDM increased with higher quartiles of fasting insulin (quartile 1 [low], 1.0; quartile 2, 1.5; quartile 3, 2.0; and quartile 4 [high], 3.7; P < 0.0001) and lower delta I30/delta G30 (quartile 1 [low], 6.9; quartile 2, 1.9; quartile 3, 1.1; quartile 4 [high], 1.0; P < 0.001). Subjects with both increased fasting insulin and decreased delta I30/delta G30 had independent increases in NIDDM incidence (P < 0.001). Further, when we stratified subjects by baseline glucose tolerance, both increased fasting insulin and decreased delta I30/delta G30 significantly predicted NIDDM in subjects with both impaired and normal glucose tolerance at baseline. We conclude that both decreased insulin secretion (as assessed by low delta I30/delta G30) and increased insulin resistance (as assessed by fasting insulin) predict the development of NIDDM in Mexican-Americans, a group previously characterized as having hyperinsulinemia and insulin resistance.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. I. Goran, C. Lane, C. Toledo-Corral, and M. J. Weigensberg Persistence of Pre-Diabetes in Overweight and Obese Hispanic Children: Association With Progressive Insulin Resistance, Poor {beta}-Cell Function, and Increasing Visceral Fat Diabetes, November 1, 2008; 57(11): 3007 - 3012. [Abstract] [Full Text] [PDF]

				G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza Effects of Nonglucose Nutrients on Insulin Secretion and Action in People With Pre-Diabetes Diabetes, April 1, 2007; 56(4): 1113 - 1119. [Abstract] [Full Text] [PDF]

				J. Munoz, K. H. Lok, B. A. Gower, J. R. Fernandez, G. R. Hunter, C. Lara-Castro, M. De Luca, and W. T. Garvey Polymorphism in the Transcription Factor 7-Like 2 (TCF7L2) Gene Is Associated With Reduced Insulin Secretion in Nondiabetic Women Diabetes, December 1, 2006; 55(12): 3630 - 3634. [Abstract] [Full Text] [PDF]

				A. H. Xiang, C. Wang, R. K. Peters, E. Trigo, S. L. Kjos, and T. A. Buchanan Coordinate Changes in Plasma Glucose and Pancreatic {beta}-Cell Function in Latino Women at High Risk for Type 2 Diabetes. Diabetes, April 1, 2006; 55(4): 1074 - 1079. [Abstract] [Full Text] [PDF]

				A. H. Xiang, R. K. Peters, S. L. Kjos, A. Marroquin, J. Goico, C. Ochoa, M. Kawakubo, and T. A. Buchanan Effect of Pioglitazone on Pancreatic {beta}-Cell Function and Diabetes Risk in Hispanic Women With Prior Gestational Diabetes Diabetes, February 1, 2006; 55(2): 517 - 522. [Abstract] [Full Text] [PDF]

				D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF]

				M. J. Weigensberg, G. D.C. Ball, G. Q. Shaibi, M. L. Cruz, and M. I. Goran Decreased {beta}-Cell Function in Overweight Latino Children With Impaired Fasting Glucose Diabetes Care, October 1, 2005; 28(10): 2519 - 2524. [Abstract] [Full Text] [PDF]

				M. J. LaMonte, S. N. Blair, and T. S. Church Physical activity and diabetes prevention J Appl Physiol, September 1, 2005; 99(3): 1205 - 1213. [Abstract] [Full Text] [PDF]

				R. Weiss, S. E. Taksali, W. V. Tamborlane, T. S. Burgert, M. Savoye, and S. Caprio Predictors of Changes in Glucose Tolerance Status in Obese Youth Diabetes Care, April 1, 2005; 28(4): 902 - 909. [Abstract] [Full Text] [PDF]

				V. Lyssenko, P. Almgren, D. Anevski, R. Perfekt, K. Lahti, M. Nissen, B. Isomaa, B. Forsen, N. Homstrom, C. Saloranta, et al. Predictors of and Longitudinal Changes in Insulin Sensitivity and Secretion Preceding Onset of Type 2 Diabetes Diabetes, January 1, 2005; 54(1): 166 - 174. [Abstract] [Full Text] [PDF]

				M. S. Remedi, Joseph. C. Koster, K. Markova, S. Seino, T. Miki, B. L. Patton, M. L. McDaniel, and C. G. Nichols Diet-Induced Glucose Intolerance in Mice With Decreased {beta}-Cell ATP-Sensitive K+ Channels Diabetes, December 1, 2004; 53(12): 3159 - 3167. [Abstract] [Full Text] [PDF]

				B. Zethelius, C. N. Hales, H. O. Lithell, and C. Berne Insulin Resistance, Impaired Early Insulin Response, and Insulin Propeptides as Predictors of the Development of Type 2 Diabetes: A population-based, 7-year follow-up study in 70-year-old men Diabetes Care, June 1, 2004; 27(6): 1433 - 1438. [Abstract] [Full Text] [PDF]

				J. I. Torrens, J. Skurnick, A. L. Davidow, S. G. Korenman, N. Santoro, M. Soto-Greene, N. Lasser, and G. Weiss Ethnic Differences in Insulin Sensitivity and {beta}-Cell Function in Premenopausal or Early Perimenopausal Women Without Diabetes: The Study of Women's Health Across the Nation (SWAN) Diabetes Care, February 1, 2004; 27(2): 354 - 361. [Abstract] [Full Text] [PDF]

				M. I. Goran, R. N. Bergman, Q. Avila, M. Watkins, G. D. C. Ball, G. Q. Shaibi, M. J. Weigensberg, and M. L. Cruz Impaired Glucose Tolerance and Reduced {beta}-Cell Function in Overweight Latino Children with a Positive Family History for Type 2 Diabetes J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 207 - 212. [Abstract] [Full Text] [PDF]

				M. Maliqueo, I. Atwater, R. Lahsen, F. Perez-Bravo, B. Angel, and T. Sir-Petermann Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of {beta}-cell dysfunction? Hum. Reprod., December 1, 2003; 18(12): 2683 - 2688. [Abstract] [Full Text] [PDF]

				A. Festa, A. J.G. Hanley, R. P. Tracy, R. D'Agostino Jr, and S. M. Haffner Inflammation in the Prediabetic State Is Related to Increased Insulin Resistance Rather Than Decreased Insulin Secretion Circulation, October 14, 2003; 108(15): 1822 - 1830. [Abstract] [Full Text] [PDF]

				J. B. Meigs, D. C. Muller, D. M. Nathan, D. R. Blake, and R. Andres The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging Diabetes, June 1, 2003; 52(6): 1475 - 1484. [Abstract] [Full Text] [PDF]

				B. O. Yildiz, H. Yarali, H. Oguz, and M. Bayraktar Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2031 - 2036. [Abstract] [Full Text] [PDF]

				M. I. Goran, G. D. C. Ball, and M. L. Cruz Obesity and Risk of Type 2 Diabetes and Cardiovascular Disease in Children and Adolescents J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1417 - 1427. [Abstract] [Full Text] [PDF]

				M. I. Goran, R. N. Bergman, M. L. Cruz, and R. Watanabe Insulin Resistance and Associated Compensatory Responses in African-American and Hispanic Children Diabetes Care, December 1, 2002; 25(12): 2184 - 2190. [Abstract] [Full Text] [PDF]

				C. C. Jensen, M. Cnop, R. L. Hull, W. Y. Fujimoto, S. E. Kahn, and the American Diabetes Association GENNID Study Gro {beta}-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S. Diabetes, July 1, 2002; 51(7): 2170 - 2178. [Abstract] [Full Text] [PDF]

				A. Carpentier, B. W. Patterson, N. Leung, and G. F. Lewis Sensitivity to Acute Insulin-Mediated Suppression of Plasma Free Fatty Acids Is Not a Determinant of Fasting VLDL Triglyceride Secretion in Healthy Humans Diabetes, June 1, 2002; 51(6): 1867 - 1875. [Abstract] [Full Text] [PDF]

				R. Sinha, G. Fisch, B. Teague, W. V. Tamborlane, B. Banyas, K. Allen, M. Savoye, V. Rieger, S. Taksali, G. Barbetta, et al. Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity N. Engl. J. Med., March 14, 2002; 346(11): 802 - 810. [Abstract] [Full Text] [PDF]

				S. Deakin, I. Leviev, V. Nicaud, M.-C. B. Meynet, L. Tiret, and R. W. James Paraoxonase-1 L55M Polymorphism Is Associated with an Abnormal Oral Glucose Tolerance Test and Differentiates High Risk Coronary Disease Families J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1268 - 1273. [Abstract] [Full Text] [PDF]

				T. W. van Haeften, W. Pimenta, A. Mitrakou, M. Korytkowski, T. Jenssen, H. Yki-Jarvinen, and J. E. Gerich Disturbances in {beta}-Cell Function in Impaired Fasting Glycemia Diabetes, February 1, 2002; 51(90001): S265 - 270. [Abstract] [Full Text] [PDF]

				C. Lorenzo, M. Serrano-Rios, M. T. Martinez-Larrad, R. Gabriel, K. Williams, C. Gonzalez-Villalpando, M. P. Stern, H. P. Hazuda, and S. M. Haffner Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations?: The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study Diabetes Care, December 1, 2001; 24(12): 2059 - 2064. [Abstract] [Full Text] [PDF]

				S. E. Kahn The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058. [Full Text] [PDF]

				T. A. Buchanan Pancreatic B-Cell Defects in Gestational Diabetes: Implications for the Pathogenesis and Prevention of Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 989 - 993. [Full Text]

				U. Lindblad, R. D. Langer, D. L. Wingard, R. G. Thomas, and E. L. Barrett-Connor Metabolic Syndrome and Ischemic Heart Disease in Elderly Men and Women Am. J. Epidemiol., March 1, 2001; 153(5): 481 - 489. [Abstract] [Full Text] [PDF]

				J. E. Gerich Insulin Resistance Is Not Necessarily an Essential Component of Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2113 - 2115. [Full Text]

				S. M. Haffner, L. Mykkanen, A. Festa, J. P. Burke, and M. P. Stern Insulin-Resistant Prediabetic Subjects Have More Atherogenic Risk Factors Than Insulin-Sensitive Prediabetic Subjects : Implications for Preventing Coronary Heart Disease During the Prediabetic State Circulation, March 7, 2000; 101(9): 975 - 980. [Abstract] [Full Text] [PDF]

				S. L. Kjos, R. K. Peters, A. Xiang, D. Thomas, U. Schaefer, and T. A. Buchanan Contraception and the Risk of Type 2 Diabetes Mellitus in Latina Women With Prior Gestational Diabetes Mellitus JAMA, August 12, 1998; 280(6): 533 - 538. [Abstract] [Full Text] [PDF]

				J. E. Gerich The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity Endocr. Rev., August 1, 1998; 19(4): 491 - 503. [Abstract] [Full Text] [PDF]

				T. Ranheim, C. Dumke, K. L. Schueler, G. D. Cartee, and A. D. Attie Interaction Between BTBR and C57BL/6J Genomes Produces an Insulin Resistance Syndrome in (BTBR x C57BL/6J) F1 Mice Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3286 - 3293. [Abstract] [Full Text]

				M. W. Mansfield, D. M. Heywood, and P. J. Grant Circulating Levels of Factor VII, Fibrinogen, and von Willebrand Factor and Features of Insulin Resistance in First-Degree Relatives of Patients With NIDDM Circulation, November 1, 1996; 94(9): 2171 - 2176. [Abstract] [Full Text]